Skip to main content

Table 3 Factors related to decreased benzodiazepines use (n = 42)

From: Effect of relaxation therapy on benzodiazepine use in patients with medically unexplained symptoms

Independent Variables

Comparison

Crude analysis

Adjusted analysisa

Adjusted analysisb

OR (95% CI)

P value

OR (95% CI)

P value

OR (95% CI)

P value

Dose used

DAP d120 mg/month increase

0.48 (0.13–1.79)

0.27

0.45 (0.11–1.78)

0.25

0.25 (0.04–1.62)

0.15

Duration since use

6 months vs 6 months<

0.06 (0.01–0.36)

< 0.01

0.04 (0.01–0.29)

< 0.01

0.04 (0.01–0.37)

< 0.01

Concomitant use of antidepressants

Yes vs no

1.66 (0.31–9.05)

0.56

1.26 (0.18–8.88)

0.81

2.32 (0.20–26.10)

0.49

Use of short-acting BZDc

Yes vs no

2.54 (0.41–15.90)

0.32

2.53 (0.38–16.60)

0.33

5.05 (0.48–53.10)

0.18

  1. aAdjusted for sex and age. bAdjusted for sex, age, and relaxation therapy modality. cBenzodiazepine. d Diazepam. OR odds ratio, CI confidence interval